Persistent Annular Eruptions in a 2‐Year‐Old Girl
Pediatric Dermatology, EarlyView.
Harisankeerth Mummareddy +3 more
wiley +1 more source
Subcutaneous panniculitis‐like T‐cell lymphoma. Survival outcomes according to the presence of hemophagocytic lymphohistiocytosis (HLH) and T category. Relapse‐free survival was inferior in patients presenting with generalized (T3) skin lesions. Overall survival was poor in patients with HLH. Relapse‐free survival was also reduced in patients with HLH.
Myoung Eun Choi +6 more
wiley +1 more source
LC-OCT for Cutaneous Lupus Erythematosus: Characterization Across Disease Subtypes and Differentiation From Rosacea. [PDF]
Traini DO +17 more
europepmc +1 more source
Narrowband UVB Induced Subacute Cutaneous Lupus Erythematosus Confined to Vitiligo Patches: A Unique Presentation. [PDF]
Herlekar R +4 more
europepmc +1 more source
Incidence of cutaneous lupus erythematosus and systemic progression: A Nationwide study in Korea. [PDF]
Song SY, Kim J, Kim YM, Ko JY.
europepmc +1 more source
Drug-induced cutaneous lupus erythematosus after 5 years of treatment with carbamazepine.
Drug-induced lupus is a disease, inducible by several drugs, that shares symptoms and laboratory characteristics with idiopathic lupus erythematosus. We report a case of carbamazepine-induced cutaneous lupus erythematosus which developed after 5 years of
C. Innocente +5 more
core
Xanthomatous Reactions in Cutaneous Lupus Erythematosus-More Than an Incidental Finding? [PDF]
Larson LM +4 more
europepmc +1 more source
Linear cutaneous lupus erythematosus/discoid lupus erythematosus in an adult [PDF]
Mao, Qiu-Xia +9 more
openaire +2 more sources
Persistent cutaneous lupus erythematosus: A pathway toward systemic disease? [PDF]
Wang Q, Chen M, Jin H, Xiao J, Zhang Y.
europepmc +1 more source
Case Report: Anifrolumab for Refractory Cutaneous Lupus Erythematosus: Relapse After Treatment Interruption and Response to Rechallenge. [PDF]
Peng Y, Stidham S, Tariq F, Zaheer M.
europepmc +1 more source

